Question 1

What is the analyst consensus rating for AVBP?

Accepted Answer

The analyst consensus rating for AVBP is "Buy" based on 4 analyst recommendations.

Question 2

What is the average price target for AVBP?

Accepted Answer

The average 12-month price target for AVBP is $41.00, representing an upside of 80.0% from the current price of $22.78.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Jan 2, 2026	Justin Zelin	BTIG	Maintains	Buy	$45.00
Dec 23, 2025	Li Watsek	Cantor Fitzgerald	Initiates	Buy	-
Dec 22, 2025	Li Watsek	Cantor Fitzgerald	Initiates	Buy	-
Dec 10, 2025	Justin Zelin	BTIG	Initiates	Strong Buy	$45.00
Dec 8, 2025	Asthika Goonewardene	Truist	Maintains	Buy	-
Dec 4, 2025	Mayank Mamtani	B Riley	Maintains	Buy	$37.00
Nov 25, 2025	Asthika Goonewardene	Truist	Initiates	Strong Buy	$43.00

ArriVent BioPharma (AVBP) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest AVBP Analyst Ratings & Recommendations